Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-CEFUROXIME DIN 02344823

Status: Marketed
Holder: AURO PHARMA INC
Molecule: CEFUROXIME (CEFUROXIME AXETIL)
Available to quote

Health Canada record

Active ingredient(s)CEFUROXIME (CEFUROXIME AXETIL) 250 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ01DC02 CEFUROXIME
Original market date13-Jan-2012
Current status date11-Jan-2021
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFUROXIME (CEFUROXIME AXETIL)

DINProductCompanyFormStrengthStatus
02244393APO-CEFUROXIMEAPOTEX INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGMarketed
02244394APO-CEFUROXIMEAPOTEX INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02344831AURO-CEFUROXIMEAURO PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02212307CEFTINSANDOZ CANADA INCORPORATEDGranules For SuspensionCEFUROXIME (CEFUROXIME AXETIL) 125 MGMarketed
02547201JAMP CEFUROXIMEJAMP PHARMA CORPORATIONTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGMarketed
02547198JAMP CEFUROXIMEJAMP PHARMA CORPORATIONTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGMarketed
02212293CEFTIN - PWR 250MG/SACHETGLAXOSMITHKLINE INCPowderCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
02212277CEFTIN - TAB 250MGGLAXOSMITHKLINE INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
02212285CEFTIN - TAB 500MGGLAXOSMITHKLINE INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02145286CEFTIN FOR ORAL SUSPENSION-PWS 250MG/PCKGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
01943049CEFTIN PWS 125MG/5MLGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME AXETIL) 125 MGCancelled Post Market
00886890CEFTIN TAB 250MGGLAXO CANADA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market
00886904CEFTIN TAB 500MGGLAXO CANADA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02230127NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Pre Market
02230125NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 125 MGCancelled Pre Market
02230126NOVO-CEFUROXIMENOVOPHARM LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Pre Market
02336448NU-CEFUROXIMENU-PHARM INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled (Unreturned Annual)
02336456NU-CEFUROXIMENU-PHARM INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled (Unreturned Annual)
02323125ORB-CEFUROXIMEORBUS PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled (Unreturned Annual)
02323117ORB-CEFUROXIMEORBUS PHARMA INCTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled (Unreturned Annual)
02311453PRO-CEFUROXIME - 500PRO DOC LIMITEETabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02242657RATIO-CEFUROXIMETEVA CANADA LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 500 MGCancelled Post Market
02242656RATIO-CEFUROXIMETEVA CANADA LIMITEDTabletCEFUROXIME (CEFUROXIME AXETIL) 250 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
249762021-01-11Abbreviated New Drug Submission (ANDS)UPDATED LABELLING MATERIALS AND CHANGE IN PRODUCT OWNERSHIP
110922010-02-25Abbreviated New Drug Submission (ANDS)
Request a quote for AURO-CEFUROXIME

How to read a Canadian DIN record